Dear friends and colleagues,
We are honored to invite you to participate in the conference “Melanoma: from basic science to clinical applications” that will be held in Reykjavik, Iceland on June 24-26, 2015 at the Harpa Concert Hall and Conference Center in Reykjavik.
Key players in the field of melanocyte and melanoma research have been invited to present their latest work on topics ranging from melanocyte development to targeted melanoma therapy. It will be an excellent opportunity to get an update on the most recent advances in this rapidly advancing field of research. We encourage you to submit your work for presentations as oral or poster presentations. A limited number of travel awards will be available for students and/or postdocs. The meeting will provide CME credits. Students (MD or PhD) and postdocs may also be interested in our course on melanoma to be held at the University of Iceland right before the conference. Those interested in taking the course are asked to register through a separate website.
Apart from science, this is an excellent time of the year to visit Iceland. During this time of year the sun almost never sets and Reykjavik is bustling with energy. Multiple sightseeing options are available before and after the conference. The conference will organize a trip to the Blue Lagoon for interested parties.
We look forward to seeing you in Reykjavik. Please contact us for any additional information or suggestions that can make your stay in Reykjavik and your participation in the meeting even more pleasant. The organizers
Robert Andtbacka, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
René Gonzalez, University of Colorado, Denver, Colorado, USA.
Lionel Larue, Institut Curie, Paris, France.
Karl Lewis, University of Colorado, Denver, Colorado, USA.
Thorunn Rafnar, Decode Genetics, Reykjavik, Iceland.
Caroline Robert, Gustave Roussy, Paris, France.
Ze’ev Ronai, Sanford Burnham Medical Research Institute, San Diego, California, USA.
Eirikur Steingrimsson, University of Iceland, Reykjavik, Iceland.